Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules

To die or not to die: death signaling in nonalcoholic fatty liver disease

(2018) Yuko Akazawa et al.   JOURNAL OF GASTROENTEROLOGY

Renoprotective effects of sodium-glucose cotransporter-2 inhibitors

(2018) Hiddo J.L. Heerspink et al.   KIDNEY INTERNATIONAL

Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study

(2018) Hye Ryoun Jang et al.   Scientific Reports

Glucagon-Like Peptide-1 and its Cleavage Products are Renoprotective in Murine Diabetic Nephropathy

(2018) Moellmann Julia et al.   DIABETES

Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis

(2018) Andrew S. Allegretti et al.   HEPATOLOGY

Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients

(2018) Agnieszka Żyłka et al.   MEDIATORS OF INFLAMMATION

Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease

(2018) Wenxia Yang et al.   CLINICAL SCIENCE

Challenging the conventional wisdom on diabetic nephropathy: Is microalbuminuria the earliest event?

(2018) Tina K. Thethi et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers

(2017) T Avril et al.   Oncogenesis

Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

(2017) Tatsuya Fukuda et al.   Diabetes Therapy

Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

(2017) Tatsuya Fukuda et al.   Diabetes Therapy

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice

(2017) Liang Xu et al.   EBioMedicine

Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization

(2017) Liang Xu et al.   Adipocyte

Angiopoietin-2 Is an Early Indicator of Acute Pancreatic-Renal Syndrome in Patients with Acute Pancreatitis

(2016) Mateusz Sporek et al.   MEDIATORS OF INFLAMMATION

Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function

(2013) Fitsum Guebre-Egziabher et al.   BIOCHIMIE

Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?

(2013) Richard E. Gilbert   KIDNEY INTERNATIONAL

Fatty liver Shionogi-ob/obmouse: A new candidate for a non-alcoholic steatohepatitis model

(2012) Takaaki Sugihara et al.   HEPATOLOGY RESEARCH

Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice

(2011) Tomomitsu Matono et al.   HEPATOLOGY RESEARCH

NASH: A global health problem

(2011) Arun J. Sanyal   HEPATOLOGY RESEARCH